Related by context. All words. (Click for frequent words.) 84 regulatory approval 79 necessary regulatory approvals 78 regulatory clearances 72 requisite regulatory approvals 71 applicable regulatory approvals 71 shareholder approvals 71 governmental approvals 70 customary regulatory approvals 69 stockholder approvals 68 approvals 66 requisite approvals 66 customary closing conditions 64 antitrust clearance 63 customary closing 59 stockholder approval 58 Pending regulatory approvals 58 consents authorizations 56 obtaining regulatory approvals 56 regulatory authorizations 56 requisite stockholder 55 lender consents 54 definitive documentation 54 approval 53 satisfactory due diligence 51 definitive agreements 51 regulatory 51 FIRB approval 51 Hart Scott Rodino 51 market PolyHeme commercially 50 securityholder approval 50 securityholder approvals 50 SFDA approval 50 requisite consents 49 Consummation 49 Regulatory Approvals 49 unitholder approval 49 successfully commercialize Iluvien 49 viii inability 49 Antitrust Improvements Act 49 NitroMed BiDil 48 disinterested shareholder 48 WDEQ Permit 48 BiDil XR drug 48 promote ceftobiprole 48 Regulatory Approval 48 Allovectin 7 r 48 consummating acquisitions 48 HSR clearance 47 MONOVISC 47 without limitation 47 USFDA approval 47 statutory clearances 47 Rotarix R 47 marketed GeoVax raises 47 regarding Heska 47 Yahoo capitulates 46 mutually acceptable definitive 46 Gestiva TM 46 ANDA filings 46 MethyPatch 46 Synerx 46 without limitation Terremark 46 EGRIFTA TM 46 Zensana 46 Hanlong transaction 46 Monovisc 45 CORLUX CORT # 45 Acquisition Transaction 45 consummation 45 transgenically produced product 45 Sular formulation 45 Investigational Device Exemption 45 ANDA submission 45 ruxolitinib 45 GLP toxicology studies 45 thetransaction 45 Aeroflex stockholders 45 Proposed Transactions 45 successfully commercialize Silenor 45 FIPB approval 45 TP# CETi 1 45 Bioenvision dependence 45 Phase IIa clinical trials 45 ZALBIN 45 Lebowa transaction 45 CompAir acquisition 45 collaborations Pharmacopeia 45 Proposed Transaction 45 Metabasis stockholders 45 GLASSIA ™ 45 disinterested Shareholder approval 45 transfusional iron overload 45 Vitaros R 45 Antitrust Improvement 45 Orosi Mill project 45 NESINA 45 Proposed Qualifying Transaction 44 risks associatedwith 44 Vitaros 44 ELEVESS 44 Pennsaid Plus 44 Visian Toric ICL 44 Mago ® 44 c SIGA 44 Solasia 44 EGRIFTA ™ 44 TNRO 44 HepaGam B R 44 authorizations 44 DRAXIS 44 Asentar TM 44 risks anduncertainties 44 PerClot 44 Increlex TM 44 KIF6 Genotyping Assay 44 Tostrex 44 compound CIP FENOFIBRATE 44 CIP TRAMADOL ER 44 vernakalant iv 44 sNDAs 44 DC Bead 44 SynthRx 44 Cellegesic 44 Completion 44 STRIANT ® 44 Xenith Corporation 44 successfully integrate 44 BugOil R 44 Entereg TM 44 HSR Act 44 LOPROX R 44 Glassia 44 BLA submission 44 Biologic License Application BLA 44 please visit www.innercool.com 44 ANDA approvals 43 VANTAS 43 Biologics License Application 43 AnGes 43 DYNACIN R Tablets 43 commercialization 43 PDTI 43 Vitaros ® 43 NeoLipid drug 43 blood thinner rivaroxaban 43 representations warranties covenants 43 Requisite Consents 43 OFIRMEV 43 ability tosuccessfully 43 Contrave NDA 43 VBV 43 PharMerica LTC Transaction 43 repopulate CNS 43 Amlodipine Besylate Tablets 43 Merger Transactions 43 MedMira rapid 43 sirtuin modulators 43 InSite reliance 43 CoStar stent 43 Prelude SkinPrep Systems 43 Sabine Pass LNG 43 tivozanib AV 43 DSL.net s 43 Exelbine 43 Somatuline R Autogel R 43 self affirmed GRAS 43 Cellu Tissue stockholders 43 d SIGA 43 commercialize alitretinoin 43 Orphan Drug designation 43 #L Sterilizer 43 zileuton IV 43 SILENOR ™ 43 Plenaxis R 43 RAPTIVA R 43 risksand uncertainties 43 Prokhorov Onexim 43 NovaDel 43 otherfactors 43 iii Cubist 43 GCF certification 43 Medigen 43 Mediaseed R 43 Shareholder Approval 43 IONSYS 43 crolibulin TM 43 ArPetrol Transaction 43 Nabi HB Intravenous 43 OTCBB CPEU 43 Clinical Trial Application 43 telavancin NDA 43 Orphan Drug Status 43 limitedto 43 Announce Shareholder Approval 43 Biological License Application 43 SYCREST 43 Somaxon ability 43 Financing Condition 43 Dyloject TM 43 chemosaturation system 43 Zensana TM 43 commercialization milestones 43 Thalomid R 43 AnorMED expectation 43 regardingthe 43 ComfortScan system 43 BiDil XR 43 Approval 42 viii 42 GRAS determination 42 vinorelbine emulsion 42 candidate Ramoplanin 42 Loramyc TM 42 eprodisate KIACTA TM 42 Allovectin 7 R 42 arenot limited 42 AzaSite Plus 42 PTCRB certification 42 refinance indebtedness 42 financings 42 Qinnan PSC 42 OTCBB BTEM 42 Definitive Agreement 42 Urokinase 42 BLA filing 42 Sturgeon Upgrader 42 definitive agreement 42 Neurogen stockholders 42 anduncertainties 42 Material License 42 Fast Track designations 42 thecompletion 42 divestitures 42 Mylan ANDA 42 VBV LLC 42 LOI contemplates 42 Oryx Pharmaceuticals 42 Junovan 42 Amitiza ® 42 Eligard R 42 Acetavance TM 42 legal proceedings xxi 42 Loramyc 42 transaction 42 divestures 42 party payor reimbursement 42 SILENOR TM 42 successfully commercialize 42 Medicis Inamed 42 commercialize BiDil 42 Zemiva TM 42 alogliptin NDA 42 JOULFERON 42 risksassociated 42 GEM #S 42 commercialize telaprevir 42 Rectogesic 42 Premarket Approval 42 PentaStaph 42 Cutanea Life Sciences 42 Flutiform TM 42 render PolyHeme obsolete 42 Daytrana TM 42 notlimited 42 JunJing III 42 mutually satisfactory definitive 42 Ceragenin ™ technology 42 QAB# indacaterol 42 Hejia Software 42 Conditional Approval 42 SonoPrep device 42 Shonin approval 42 CLIA waiver 42 CanElson 42 statementsregarding 42 Flutiform ™ 42 Teflaro 42 5 lipoxygenase inhibitor 42 AMEX IVX LSE IVX.L 42 incur unanticipated 42 OraTest R 42 rapid prototyping patents 42 Nycomed GmbH 42 FCC PTCRB 42 vernakalant oral 42 IND CTA 41 Business Combination 41 lorcaserin NDA 41 commercialized DURECT 41 uncertainties 41 Chaim Lebovits President 41 Company Skouries Olympias 41 BioGlue ® 41 Ondansetron Injection 41 finalization 41 proceeds therefrom 41 Shigamabs 41 Combination Transaction 41 contractual arrangements 41 AMEX OTD 41 Mitsue Pipelines 41 Gwenco 41 Loramyc ™ 41 Cellegy 41 ZEGERID Powder 41 PLAVIX R patent 41 Lumera stockholders 41 daily Glumetza TM 41 No Objection Letter 41 Generx TM 41 orally bioavailable compound 41 Allovectin 7 41 Merial Intervet 41 CRINONE ® 41 Saforis 41 EDQM 41 Kinsevere copper mine 41 generic Valtrex 41 Metricath Gemini 41 ANDA abbreviated 41 PMA submission 41 redomiciliation 41 party payors 41 Final Approval 41 Fortesta 41 successfully commercialized 41 Omigard 41 GMP certification 41 Nabi HB R 41 ZEGERID Capsules 41 warrantholder approval 41 consents 41 deploy MDCE services 41 Rozetta Cell 41 markets HP Acthar 41 distributorship agreements 41 JZP 6 41 faropenem 41 CenturyLink Qwest merger 41 Methylphenidate Transdermal System 41 Amlodipine Besylate 41 Cytokinetics specified 41 Power3 patent 41 PolyHeme successfully 41 VYVANSE TM lisdexamfetamine 41 Argatroban 41 sumatriptan DosePro 41 FDA approvable letter 41 Exelon Patch 41 PD2i Analyzer ™ 41 Bullabulling Gold Project 41 SurModics Pharmaceuticals 41 generic atorvastatin 41 IV APAP 41 Solfotara Mining Corporation 41 expectations anticipations estimates 41 proprietary Capillary Aerosolization Technology 41 statements arebased 41 NV Organon 41 SILENOR 41 incorporate CXA 41 AMID Stapler ™ 41 MOZOBIL 41 commercialize ZYFLO CR 41 KRYSTEXXA TM 41 asset monetizations 41 Reverse Takeover 41 NDA submission 41 Proposed Acquisition 41 Proposed Amalgamation 41 CapGen Offering 41 ENRICH trial 41 Canetic Unitholders 41 ReNvision 41 Fortigel 41 ADSI reliance 41 IV acetaminophen 41 Marketing Authorization Applications 41 Preotact 41 Flexpipe 41 Yima project 41 party VLSI fabrication 41 InKine 41 TRISENOX ® 41 Type Inbox 41 AETI SEC 41 Approvable Letter 41 OTC ZEGERID 41 OIO approval 41 LEP ETU 41 MAb therapy 41 CalciTech products 41 OrCrude TM process 41 Nemak transaction 41 Gestiva ™ 41 Recapitalization Transaction 41 CLIA certification 41 Gentamicin Surgical Implant 41 StaphVAX 41 Entereg R 41 Marketing Authorisation Application 41 OMAPRO ™ 41 JUVISTA 41 CryoSeal 41 BioGlue R 41 Eligard ® 41 GVAX Immunotherapies 41 TriPath Oncology 41 uncertaintiesthat 41 cadence regulatory approvals 41 Proposed Financing 41 Alnylam dependence 41 naronapride 41 PrevOnco 41 customary representations warranties 41 Falconbridge Acquisition 41 BEMA Granisetron 41 consummated 41 Lexiscan R 41 shares issuable pursuant 41 generic Lipitor 41 Alvheim Vilje development 41 drug ISA# 41 Biomerge 41 cytokine immunomodulator 41 Trizytek 41 enoxaparin sodium injection 41 Heska reliance 41 Equitex 41 Stavzor 41 ORTHOVISC mini 41 ANDA 41 severe hypercholesterolemia 41 Cutanea 41 Oncosphere 40 generic Copaxone 40 Fluviral 40 IND Investigational New 40 Poly ICR 40 Paragraph IV certifications 40 Progenta TM 40 DeeThree 40 CONBRIZA 40 Aphthasol R 40 KRYSTEXXA 40 zileuton CR 40 Kosan dependence 40 Orathecin 40 Linjeta TM 40 Invicorp R 40 requirements xxii 40 Levoleucovorin 40 Evoltra ® 40 conditioned upon 40 CORTOSS 40 Vicor anticipates 40 Interpharm 40 USEB Chapter 40 non waivable 40 authority NMa 40 AMID Stapler TM 40 ZEGERID Chewable Tablets 40 affecting Amarin 40 bilastine 40 Marketing Authorization 40 minimally dilutive 40 BioDelivery Sciences Announces 40 hoFH 40 daily bactericidal antibiotic 40 Approvals 40 TaiGen 40 cancellations rescheduling 40 Paredones Amarillos Project 40 ATryn ® 40 PTCRB 40 BioThrax ® 40 Irinotecan Hydrochloride Injection 40 iChem VELOCITY 40 Submits Response 40 Trubion stockholders 40 including withoutlimitation 40 Comdial Corporation 40 apaziquone 40 ourability 40 crinobulin 40 Inovio pipeline 40 Topiramate Tablets 40 histamine dihydrochloride 40 Fampridine SR Acorda Therapeutics 40 mesylate tablets approved 40 Civacir 40 Definitive Agreements 40 Crisa acquisition 40 Primera Bioscience 40 PROMUS Element Stent System 40 Upon consummation 40 Shire plc Attention Deficit 40 adversely affect Linktone 40 SUPPRELIN LA 40 execute supplemental indenture 40 Announces Tentative Approval 40 permitting timelines 40 & Workover Fluids 40 FIPB nod 40 ANDAs pending approval 40 TRANSDUR Sufentanil 40 Somatuline R Depot 40 Company nanocrystalline materials 40 Eloxatin ® 40 trading symbol GCKO 40 Google Permissions 40 EPIX Pharmaceuticals 40 andgeneral 40 IMMUNITY FX 40 Public Utilities Commissions 40 CEFF financings subject 40 results ofoperations 40 xxi 40 Oranje Nassau Groep BV 40 UL certifications 40 Fanapt ™ 40 SURFAXIN 40 HSR Antitrust Improvements 40 Cobalt Pharmaceuticals 40 JHP Pharmaceuticals LLC 40 private placement 40 Keystone Pipeline System 40 Flutiform 40 Rosetta dependence 40 Submits Application 40 Synvisc ONE 40 ColonSentry TM test 40 PVC Additives 40 Evoltra TM 40 Safe Harbors created 40 synergies therefrom 40 THELIN 40 Inhibiton 40 Surfaxin lucinactant 40 PentaLyte R 40 Pantarhei 40 IND submission 40 Lero Gold 40 Zevtera 40 Rasilez HCT 40 mifamurtide 40 QMLP 40 Marketing Authorizations 40 SuperStitch ® 40 MAXY alpha 40 Unifill syringe 40 BRILINTA 40 OLpur TM H2H 40 REPLAGAL 40 vii 40 Emezine 40 payer reimbursement 40 MDVIP collects 40 xi Immtech ability 40 miconazole MBT 40 NSE SUNPHARMA 40 Aurvista 40 valid acceptances 40 TAXUS Element Stent System 40 Unifill TM syringe 40 FACTIVE R gemifloxacin 40 Arrangement Agreement 40 APF# NDA 40 authority Gurian Sherman 40 accretive 40 Aloprim TM allopurinol sodium 40 commercialize CorMedix drug 40 Proposed Combination 40 indebtedness incurred 40 PREOS R 40 HYVISC R 40 ORBIT II 40 Wikifamilies 40 Form #c# 40 TranSwitch indebtedness 40 Daewoong 40 OvaRex ® MAb 40 Chihong 40 CholeraGarde R Peru 40 RAPIDGate Program contains 40 Bellus Health 40 European Marketing Authorizations 40 NerPharMa 40 Amoxicillin PULSYS Phase III 40 Applications ANDA 40 ISO Certification 40 Zeneus 40 PROCHIEVE ® 40 exemptive relief 40 CEMATRIX 40 affecting BEO Bancorp 40 attaching thereto 40 renamed Gavilon LLC 40 FDA Approvable Letter 40 ColorectAlert TM 40 Reloxin R 40 highly purified pasteurized 40 Allegra ® 40 BioZone 40 Thelin TM 40 requisite clearances 40 website www.nyandcompany.com 40 Sangaredi Refinery Project 40 Michelago Limited 40 Adamis Pharmaceuticals Corporation 40 rolapitant 40 eSVS MESH 40 Nasdaq NPSP announced 40 GEM #S ® 40 Marketing Authorisation Application MAA 40 Somanta 40 ThromCat 40 vaginal lidocaine 40 hyperimmune products 40 Marketing Authorization Application 40 transactions contemplated 40 Kyowa Kirin 40 Multiplied Media announces 40 CardioMag 40 Orthovita filings 40 ESTRASORB R 40 Visudyne R 40 novel therapeutic modality 40 Vibativ 40 Mutual Recognition Procedure 40 Zila stockholders 40 Campto 40 Drug Applications ANDAs 40 Application BLA 40 Orphan Drug designations 40 Eurogas International 39 gastrointestinal disorders ATI 39 Calixa 39 cethromycin NDA 39 DASA Finance 39 theacquisition 39 Ceragenin TM technology 39 meaningfully accretive 39 product introductions 39 Zolpidem Tartrate Tablets 39 OGE Enogex Partners LP 39 mergers consolidations 39 candidate AQ4N 39 Modrenal R 39 confirmatory Phase III 39 Symphony tCGM System 39 IPM Wound Gel 39 unfavorable geologic 39 HepeX B 39 Merger Transaction 39 Brokered Financing 39 Biophan patent 39 Bioral Amphotericin B 39 Junovan TM 39 specify Kirrin News 39 Sabex Holdings Ltd. 39 Stimuvax R 39 suspensive conditions 39 differ materially 39 Soliris eculizumab 39 AtheroNova filings 39 Kevitsa project 39 KIACTA TM 39 Gestiva 39 Sumatriptan Succinate Tablets 39 Camp Caiman project 39 redundancy scalability 39 EvaMist NDA submission 39 CAMPATH 39 Scivanta Medical Corporation 39 Periostat 39 diagnostic radiopharmaceutical 39 Exelixis compounds 39 payor acceptance 39 wagering ceasing 39 Lovaza TM 39 GLASSIA 39 symbol GEX 39 Xechem Nigeria 39 vii Cubist ability 39 AVINZA ® 39 PD2i Analyzer 39 received CE Conformite 39 BioGold Fuels 39 Inc. NYSE MYL 39 Eligard 39 Famy Care 39 sporicidal product 39 Vasovist 39 OctoPlus NV 39 Kirin Pharma 39 Elevess 39 Shire BioChem Inc. 39 SOLODYN R 39 New Drug Application 39 TOCOSOL Paclitaxel 39 Akorn Strides 39 Prestara 39 cMET inhibitor 39 Enjuvia 39 approve telavancin 39 TRANSDUR Bupivacaine 39 liver resection surgeries 39 spokeswoman Alison Marquiss 39 PLIVA dd 39 Metformin GR 39 collaborations Pharmacopeia anticipated 39 TSX PLB leading 39 Kaboose trades 39 sumatriptan injection 39 flu vaccine Fluarix 39 Xenith Bankshares 39 Oracea ® 39 Soliris TM eculizumab 39 Peregrino field 39 Prednisporin 39 SMNA analyzes 39 Captisol ® 39 FACTIVE tablets 39 market fluctuations investee 39 autoimmune indications 39 sBLA 39 XL# anticancer compounds 39 Eucreas 39 involve risks anduncertainties 39 molecular immunohematology products 39 Guidant stent 39 SansRosa 39 Ascend Therapeutics 39 CE Marking 39 Orapred ODT 39 iv 39 developing ostarine selective 39 pulls Darvon painkiller 39 progesterone gel 39 TWYNSTA ® 39 Concurrent Financing 39 PetroEdge 39 Lamictal ODT 39 clearance eg probenecid 39 Orphan Status 39 Rotarix ® 39 IntelliPharmaCeutics Ltd. 39 methods Spillars 39 PIX# trial 39 Fast Track designation 39 Valortim TM 39 Urocidin 39 FavId 39 CIP Fenofibrate 39 SEBIVO 39 FIRAZYR 39 COPL 39 Drug Submission 39 Release Capsules 39 dividends Annaly 39 rThrombin 39 Fibrocaps 39 symbol LGO 39 Pharmos pipeline 39 Synerx Pharma 39 XP# XP# 39 Phase IIa trials 39 Kosan motilin agonist 39 Severe hypersensitivity reactions 39 Nicotine Conjugate Vaccine 39 subsidiary Glenmark Generics 39 ZURICH AFX Novartis AG 39 TOCOSOL Camptothecin 39 becompleted 39 Bioaccelerate compounds under 39 SuperStitch R 39 compound CXA 39 Exelbine NDA 39 Rheoscience 39 Valera Pharmaceuticals Inc. 39 Galephar 39 multipurpose tweendeckers 39 Exalgo 39 ZEFTERA TM Zevtera TM 39 creditworthy shippers 39 PROMACTA ® 39 plastic photochromic lens 39 EIFH 39 Receives Conditional 39 Medtronic Annual Report 39 Miikana 39 Lexiscan TM 39 iQuran offer 39 candidate XP# 39 TheraCIM 39 Diavik Mine 39 Finalization 39 IMPDH inhibitor 39 Kensington Leasing 39 Harrah's Caesars merger 39 Tranzeo logo 39 Aloxi Injection 39 k premarket 39 PREGNANT Study 39 withrespect 39 cicletanine 39 Insegia 39 CUBICIN 39 fund BioSante LibiGel 39 Laboratorios Rimafar 39 Insure.com generates revenues 39 NEBIDO 39 Zidovudine Tablets 39 HydroFix ™ 39 divestiture 39 Crux liquids project 39 Scivanta 39 affect Petroflow 39 forodesine HCl 39 Marketing Authorization Application MAA 39 Debenture Financing 39 Offer Period 39 Cefprozil 39 especially Copaxone ® 39 Marketing Authorisation 39 Clearant Process ® 39 Qualifying Transaction pursuant 39 Cinryze TM 39 covenant waivers 39 Biologic License Application 39 BioSTAR ® 39 Syntroleum Process 39 DIP financing facility 39 securities issuable pursuant 39 Phase III LibiGel 39 balsalazide tablet 39 Nasdaq IMDC 39 substantial indebtedness 39 Submits Biologics License Application 39 BEMA Fentanyl 39 Ceplene histamine dihydrochloride 39 pharmacokinetic feasibility 39 NASDAQ CHIP VeriChip 39 oral calcitonin 39 confirmatory due diligence 39 Vascular Wrap TM 39 JM Dutton adds 39 outstanding indebtedness 39 Prodarsan R 39 risks uncertainties 39 Orphan Drug status 39 Symbicort asthma 39 BioOne Corporation 39 GRAS notification 39 immediately accretive 39 Shigamabs R 39 SouthFirst 39 Vertex Pharma 39 practicable thereafter 39 Angiotech Entities 39 acquisition 39 GHL Acquisition stockholders 39 RedHill 39 Isis Alnylam 39 VioQuest 39 financing 39 BioSante licensees 39 CE Marked 39 OvaRex R 39 Milestone Payment From 39 STEDESA 39 Omigard TM 39 sumatriptan succinate tablets 39 acquisitions divestitures strategic alliances 39 Avance Gas 39 intravenous formulations 39 Algatec 39 Formal Agreements 39 Sumatriptan Succinate 39 biosurgical 39 Preotact R 39 Multiferon R 39 Commitment Letter 39 Loramyc ® 39 Acapodene R 39 Dalian Jinchuan 39 dimesylate Attention Deficit 39 known teratogen substance 39 Jinan Fertilizer 39 Fast Track Status 39 Risks uncertainties 39 histrelin manufacturing marketing 39 Hedrin 39 permits consents 39 Immtech clinical trials 38 Oncoscience AG 38 Shin Poong 38 Loetschberg tunnel 38 Boyuan 38 SANCTURA R 38 MCCSR 38 Lasertel subsidiary 38 Files Investigational 38 xxv 38 k Premarket Notification 38 sevelamer carbonate 38 specify Alturas 38 BioSTAR R 38 ELADUR 38 Glaxo Cervarix 38 MEZAVANT 38 Evoltra R 38 Bionutrics 38 Accelerated Feasibility Study 38 Tendering holders 38 Cefprozil tablets 38 UNEV 38 SNBI 38 Non Brokered Offering 38 ReAble Therapeutics Inc. 38 DMFs 38 RAPTIVA r 38 Aurobindo Pharma Ltd 38 SUMAVEL 38 intravenous acetaminophen 38 Frova ® 38 LE SN# 38 Graniz Loan 38 Physhield Insurance Exchange 38 inhaled AAT 38 MPEH ™ 38 GMP Certification 38 Urocidin TM 38 candidate Zemiva TM 38 ZCI Offer 38 causeactual results 38 cintredekin besudotox 38 Fund TSX CHW.UN 38 ViaCord R 38 Risperidone Oral Solution 38 Federated Kaufmann Funds 38 Shire Attention Deficit 38 KRYSTEXXA ™ 38 subsidiaries visit http:/www.apricusbio.com 38 orBec R 38 CHMP recommendation 38 initiate Phase IIb 38 EpiCept NP 1 38 PROCHIEVE 38 Certican 38 Qualifying Transaction 38 MEPACT 38 EHT AGN 38 Oracea TM 38 Zanaflex Capsules competition 38 CDP# 38 Phase III clinical trials 38 Monovisc TM 38 COGECO subordinate voting 38 R isosorbide dinitrate 38 Estrasorb 38 Surfaxin LS 38 NYSE Amex PTN 38 FRP pipe 38 Receives Stockholder Approval 38 FORTIS M trial 38 notifiable transaction 38 pediatric exclusivity 38 AcryMed Incorporated 38 Onco TCS 38 capture exosomes 38 Td vaccine 38 Transamerica reinsurance 38 Telephone Replay Will 38 Fanapt TM iloperidone 38 iii GTx 38 Voraxaze 38 Generex Oral lyn tm 38 Aclasta Reclast 38 Dynepo 38 alogliptin 38 DJO Merger 38 file INDs 38 Nasdaq MYL 38 ticker symbol IMM 38 Terminates Agreement 38 warrantholders 38 Taiho Pharmaceutical 38 manufacture PolyHeme 38 OMNARIS HFA 38 BENLYSTA ® 38 DIFICID ™ 38 Vele coking coal 38 submitted supplemental Biologics 38 Promus Element stent 38 ADVENTRX 38 USPoly 38 Edgen Corporation